These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2903105)

  • 1. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
    Giordano C; Pantŏ F; Amato MP; Sapienza N; Pugliese A; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):611-7. PubMed ID: 2252529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
    Dupre J; Jenner MR; Mahon JL; Purdon C; Rodger NW; Stiller CR
    Diabetes; 1991 May; 40(5):598-604. PubMed ID: 2022304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
    Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
    Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
    Snorgaard O; Hartling SG; Binder C
    Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study.
    Müller C; Zielinski CC; Kalinowski W; Wolf H; Mannhalter JW; Aschauer-Treiber G; Klösch-Kasparek D; Gaube S; Eibl MM; Schernthaner G
    J Endocrinol; 1989 Apr; 121(1):177-83. PubMed ID: 2654321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose homeostasis and insulin secretion during chronic treatment with cyclosporin in nondiabetic humans.
    Robertson RP; Franklin G; Nelson L
    Diabetes; 1989 Jan; 38 Suppl 1():99-100. PubMed ID: 2642866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of cyclosporin A in patients with newly diagnosed type 1 diabetes mellitus.
    Feldt-Rasmussen B; Jensen T; Dieperink H; Mandrup-Poulsen T; Nerup J; Bendtzen K; Andersen V; Kemp E; Leyssac PP
    Diabet Med; 1990 Jun; 7(5):429-33. PubMed ID: 2142040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven years of remission in a type I diabetic patient.
    Koivisto VA; Leirisalo-Repo M; Ebeling P; Tuominen JA; Knip M; Turunen U; Mandrup-Poulsen T; Pelkonen R
    Diabetes Care; 1993 Jul; 16(7):990-5. PubMed ID: 8359107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr.
    Snorgaard O; Lassen LH; Binder C
    Diabetes Care; 1992 Aug; 15(8):1009-13. PubMed ID: 1505301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.
    Cook JJ; Hudson I; Harrison LC; Dean B; Colman PG; Werther GA; Warne GL; Court JM
    Diabetes; 1989 Jun; 38(6):779-83. PubMed ID: 2656346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.